Your browser doesn't support javascript.
loading
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
Bayraktar, Soley; Zhou, Jade Z; Bassett, Roland; Gutierrez Barrera, Angelica M; Layman, Rachel M; Valero, Vicente; Arun, Banu.
Afiliación
  • Bayraktar S; Division of Medical Oncology and Hematology, Department of Medicine, Biruni University School of Medicine, Istanbul, Turkey.
  • Zhou JZ; Departments of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Bassett R; Departments of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Gutierrez Barrera AM; Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Layman RM; Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Valero V; Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Arun B; Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Breast J ; 26(8): 1572-1582, 2020 08.
Article en En | MEDLINE | ID: mdl-32497289

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mutación de Línea Germinal Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast J Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mutación de Línea Germinal Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast J Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Turquía